New therapeutic approaches in sepsis: A critical review

L. A. Eidelman, R. Pizov, C. L. Sprung

Research output: Contribution to journalArticlepeer-review

Abstract

This paper reviews several recent, randomized, double-blind, placebo-controlled trials of monoclonal antibodies against endotoxin, interleukin-1 receptor antagonist (IL-1 ra), and monoclonal antibody against tumor necrosis factor (TNF) in sepsis.

Original languageEnglish
Pages (from-to)S269-S272
JournalIntensive Care Medicine
Volume21
Issue number2 Supplement
DOIs
StatePublished - Nov 1995
Externally publishedYes

Keywords

  • Endotoxin
  • Interleukin-1 receptor antagonist
  • Mediators
  • Monoclonal antibodies
  • Sepsis
  • Tumor necrosis factor

Fingerprint

Dive into the research topics of 'New therapeutic approaches in sepsis: A critical review'. Together they form a unique fingerprint.

Cite this